Ken Griffin’s Axogen AXGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $328K | Buy |
9,900
+1,100
| +13% | +$35.8K | ﹤0.01% | 10278 |
|
|
2025
Q4 | $288K | Sell |
8,800
-23,800
| -73% | -$585K | ﹤0.01% | 10238 |
|
|
2025
Q3 | $582K | Buy |
32,600
+13,500
| +71% | +$196K | ﹤0.01% | 8758 |
|
|
2025
Q2 | $207K | Sell |
19,100
-25,100
| -57% | -$329K | ﹤0.01% | 10606 |
|
|
2025
Q1 | $818K | Buy |
44,200
+9,700
| +28% | +$175K | ﹤0.01% | 7392 |
|
|
2024
Q4 | $569K | Buy |
34,500
+8,800
| +34% | +$125K | ﹤0.01% | 8279 |
|
|
2024
Q3 | $360K | Sell |
25,700
-14,400
| -36% | -$159K | ﹤0.01% | 8930 |
|
|
2024
Q2 | $290K | Sell |
40,100
-600
| -1% | -$4.1K | ﹤0.01% | 9211 |
|
|
2024
Q1 | $328K | Buy |
40,700
+38,600
| +1,838% | +$346K | ﹤0.01% | 9264 |
|
|
2023
Q4 | $14.3K | Sell |
2,100
-20,100
| -91% | -$112K | ﹤0.01% | 12881 |
|
|
2023
Q3 | $111K | Sell |
22,200
-55,800
| -72% | -$386K | ﹤0.01% | 10761 |
|
|
2023
Q2 | $712K | Sell |
78,000
-37,800
| -33% | -$352K | ﹤0.01% | 7158 |
|
|
2023
Q1 | $1.09M | Buy |
115,800
+57,300
| +98% | +$524K | ﹤0.01% | 6569 |
|
|
2022
Q4 | $584K | Buy |
58,500
+23,900
| +69% | +$265K | ﹤0.01% | 7922 |
|
|
2022
Q3 | $412K | Sell |
34,600
-52,800
| -60% | -$528K | ﹤0.01% | 8893 |
|
|
2022
Q2 | $716K | Sell |
87,400
-68,900
| -44% | -$589K | ﹤0.01% | 7809 |
|
|
2022
Q1 | $1.24M | Buy |
156,300
+79,500
| +104% | +$687K | ﹤0.01% | 7211 |
|
|
2021
Q4 | $720K | Buy |
+76,800
| New | +$921K | ﹤0.01% | 8765 |
|
|
2021
Q3 | – | Sell |
-9,500
| Closed | -$205K | – | 13783 |
|
|
2021
Q2 | $205K | Sell |
9,500
-13,900
| -59% | -$281K | ﹤0.01% | 12101 |
|
|
2021
Q1 | $474K | Sell |
23,400
-26,100
| -53% | -$515K | ﹤0.01% | 9784 |
|
|
2020
Q4 | $886K | Buy |
49,500
+38,100
| +334% | +$560K | ﹤0.01% | 7046 |
|
|
2020
Q3 | $133K | Buy |
+11,400
| New | +$132K | ﹤0.01% | 9085 |
|
|
2020
Q1 | – | Sell |
-15,400
| Closed | -$276K | – | 9563 |
|
|
2019
Q4 | $276K | Buy |
15,400
+3,600
| +31% | +$53.2K | ﹤0.01% | 7713 |
|
|
2019
Q3 | $147K | Sell |
11,800
-3,800
| -24% | -$62.6K | ﹤0.01% | 8311 |
|
|
2019
Q2 | $309K | Sell |
15,600
-3,500
| -18% | -$74.9K | ﹤0.01% | 7542 |
|
|
2019
Q1 | $402K | Buy |
19,100
+5,400
| +39% | +$98.6K | ﹤0.01% | 7156 |
|
|
2018
Q4 | $280K | Sell |
13,700
-600
| -4% | -$18.8K | ﹤0.01% | 7388 |
|
|
2018
Q3 | $527K | Buy |
14,300
+5,700
| +66% | +$249K | ﹤0.01% | 6605 |
|
|
2018
Q2 | $432K | Buy |
+8,600
| New | +$379K | ﹤0.01% | 6617 |
|
Other funds holding AXGN
FLAM
VCM
ACH
WA
PCH
Ken Griffin's AXGN Position: Q1 2026 in Review
Ken Griffin increased its Axogen (AXGN) stake by 65% in Q1 2026, buying an estimated $3.13M and bringing the position to 245,054 shares worth $8.12M. The position accounts for ﹤0.01% of the portfolio, ranked #3560.
Ken Griffin first reported a position in AXGN in Q2 2017 and has held it in 32 quarters since. 221 funds tracked by Wall St. Rank hold AXGN as of Q1 2026.
- Ken Griffin held 245,054 shares of Axogen worth $8.12M as of Q1 2026.
- Ken Griffin bought 96,330 Axogen shares in Q1 2026, an estimated $3.13M.
- Axogen made up ﹤0.01% of Ken Griffin's portfolio in Q1 2026, its #3560 holding.
- Ken Griffin first reported a position in Axogen in Q2 2017 and has held it in 32 quarters since.
- 221 funds tracked by Wall St. Rank held Axogen as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.